Gilead Sciences Stock Price

0.12 (0.17%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Gilead Sciences Inc GILD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.12 0.17% 71.00 0.00 0.00 0.00 70.88 08:44:17
Bid Price Ask Price Spread Spread % News
70.92 71.00 0.08 0.11% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
198 10,334 $ 71.03 $ 734,044 8,114,065 60.89 - 89.00
Last Trade Time Type Quantity Stock Price Currency
08:44:54 50 $ 70.9999 USD

Gilead Sciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 89.09B 1.25B 1.25B $ 22.45B $ 4.08B 4.21 18.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 2.52 3.55% - -

more financials information »

Gilead Sciences News

Date Time Source News Article
8/03/202007:29Dow Jones NewsGilead Shows the Dangers of Covid-19 Drug Mania -- Heard on..
7/30/202020:27Dow Jones NewsGilead Swings to Quarterly Loss on Higher Costs -- Update
7/30/202018:58Edgar (US Regulatory)Current Report Filing (8-k)
7/30/202017:33Dow Jones NewsGilead Swings to Quarterly Loss on Higher Costs
7/30/202017:17Dow Jones NewsGilead Revises Annual Guidance
7/30/202016:46Dow Jones NewsGilead Swings to 2Q Loss Following Acquisition and..
7/30/202016:02Business WireGilead Sciences Announces Third Quarter 2020 Dividend
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GILD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week73.8574.5068.5271.1111,280,513-2.85-3.86%
1 Month76.7078.9468.5274.237,727,785-5.70-7.43%
3 Months79.3480.8068.5275.049,463,911-8.34-10.51%
6 Months66.2289.0064.0775.3617,336,3794.787.22%
1 Year64.3089.0060.8972.4712,025,5106.7010.42%
3 Years72.8089.5460.1072.608,895,250-1.80-2.47%
5 Years119.70120.0760.1077.319,059,836-48.70-40.69%

Gilead Sciences Description

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition and pending Forty-Seven acquisition boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Your Recent History
Gilead Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200805 13:00:40